Field seasonal influenza vaccine effectiveness: Evaluation of the screening method using different sources of data during the 2010/2011 French influenza season

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 11, 2013, Pages 2453-2459

  Falchi, Alessandra ^a,b,c   Souty, Cecile ^a,c   Grisoni, Marie Lise ^a,c   Mosnier, Anne ^d   Hanslik, Thomas ^a,e,f   Daviaud, Isabelle ^d   Varesi, Laurent ^a,b   Kerneis, Solen ^a,c   Carrat, Fabrice ^a,c,g   Blanchon, Thierry ^a,c  

^a INSERM   (France)

^b UNIVERSITÉ DE CORSE   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d Réseau des Groupes Régionaux d'Observation de la Grippe GROG Coordination Nationale   (France)

^e LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^f HÔPITAL AMBROISE PARÉ   (France)

^g HÔPITAL SAINT ANTOINE   (France)

Author keywords

General practitioners; Influenza; Target groups; Vaccination coverage; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; CHRONIC DISEASE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG CHOICE; DRUG EFFICACY; FRANCE; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; INFANT; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; REVIEW; SCREENING TEST; SEASONAL INFLUENZA; ADOLESCENT; CHILD; FEMALE; INFLUENZA, HUMAN; INFORMATION PROCESSING; MALE; MIDDLE AGED; PRESCHOOL CHILD; PROCEDURES; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; FEMALE; FRANCE; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84887457491     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.25513     Document Type: Review

References (28)

1. Guthmann JP, Fonteneau L, Bonmarin I, Lévy-Bruhl D. Infuenza vaccination coverage one year after the A(H1N1) infuenza pandemic, France, 2010-2011. Vaccine 2012; 30: 995-7; PMID: 22178520; http://dx.doi.org/10.1016/j. vaccine.2011.12.011
2. Tuppin P, Choukroun S, Samson S, Weill A, Ricordeau P, Allemand H. [Vaccination against seasonal infuenza in France in 2010 and 2011: decrease of coverage rates and associated factors]. Presse Med 2012; 41:e568-76; PMID: 22795870; http://dx.doi.org/10.1016/j.lpm.2012.05.017
3. Tuppin P, Samson S, Weill A, Ricordeau P, Allemand H. Seasonal infuenza vaccination coverage in France during two infuenza seasons (2007 and 2008) and during a context of pandemic infuenza A(H1N1) in 2009. Vaccine 2011; 29: 4632-7; PMID: 21550376; http://dx.doi.org/10.1016/j.vaccine.2011.04.064
4. Recommended viruses for infuenza vaccines for use in the 2010-2011 northern hemisphere infu-enza season. Wkly Epidemiol Rec 2010; 85: 81-92; PMID: 20210260
5. Bonmarin I, Belchior E, Le Strat Y, Levy-Bruhl D. First estimates of infuenza vaccine effectiveness among severe infuenza cases, France, 2011/12. Euro Sur veill 2012; 17: 17; PMID: 22587956
6. Kissling E, Valenciano M; I-MOVE Case-Control Studies Team. Early estimates of seasonal infuenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicen-tre case-control study, 2011/12. Euro Surveill 2012; 17: 17; PMID: 22516046
7. Va lleron AJ, Bouvet E, Garnerin P, Ménarès J, Heard I, Letrait S, et al. A computer network for the surveillance of communicable diseases: the French experiment. Am J Public Health 1986; 76: 1289-92; PMID: 3766824; http://dx.doi.org/10.2105/AJPH.76.11.1289 (Pubitemid 17168422)
8. Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine effcacy in the feld. Further observations. Epidemiol Rev 1988; 10: 212-41; PMID: 3066628 (Pubitemid 18262846)
9. Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, et al. Field evaluation of vaccine effcacy. Bull World Health Organ 1985; 63: 1055-68; PMID: 3879673
10. Legrand J, Vergu E, Flahault A. Real-time monitoring of the infuenza vaccine feld effectiveness. Vaccine 2006; 24: 6605-11; PMID: 16806607; http://dx.doi.org/10.1016/j.vaccine.2006.05.063 (Pubitemid 46127433)
11. Costagliola D. When is the epidemic warning cutoff point exceeded? Eur J Epidemiol 1994; 10: 475-6; PMID: 7843360; http://dx.doi.org/10.1007/BF01719680 (Pubitemid 24339219)
12. Review of the 2010-2011 winter infuenza season, northern hemisphere. Wkly Epidemiol Rec 2011; 86: 222-7; PMID: 21661271
13. Orenstein EW, De Serres G, Haber MJ, Shay DK, Bridges CB, Gargiullo P, et al. Methodologic issues regarding the use of three observational study designs to assess infuenza vaccine effectiveness. Int J Epidemiol 2007; 36: 623-31; PMID: 17403908; http://dx.doi.org/10.1093/ije/dym021 (Pubitemid 47244566)
14. Cardellino A, Khawaja S, Sanchez Cruz E, Mast TC. Effectiveness of vaccination with the pentavalent rotavirus vaccine in Nicaragua as determined using the screening method. Hum Vaccin Immunother 2013; 9; In Press. PMID: 23571175; http://dx.doi.org/10.4161/hv.24338
15. Valenciano M, Kissling E, Ciancio BC, Moren A. Study designs for timely estimation of infu-enza vaccine effectiveness using European sentinel practitioner networks. Vaccine 2010; 28: 7381-8; PMID: 20851086; http://dx.doi.org/10.1016/j. vaccine.2010.09.010
16. Jiménez-Jorge S, Savulescu C, Pozo F, de Mateo S, Casas I, Ledesma J, et al.; cycEVA Study Team; Spanish Infuenza Sentinel Surveillance System. Effectiveness of the 2010-11 seasonal trivalent infu-enza vaccine in Spain: cycEVA study. Vaccine 2012; 30: 3595-602; PMID: 22472792; http://dx.doi.org/10. 1016/j.vaccine.2012.03.048
17. Kissling E, Valenciano M, Cohen JM, Oroszi B, Barret AS, Rizzo C, et al. I-MOVE multi-centre case control study 2010-11: overall and stratifed estimates of infuenza vaccine effectiveness in Europe. PLoS One 2011; 6:e27622; PMID: 22110695; http://dx.doi.org/10.1371/journal.pone.0027622
18. Englund H, Campe H, Hautmann W. Effectiveness of trivalent and monovalent infuenza vaccines against laboratory-confrmed infuenza infection in persons with medically attended infuenza-like illness in Bavaria, Germany, 2010/2011 season. Epidemiol Infect 2012: 1-9; In Press. PMID: 23098364; http://dx.doi.org/10.1017/S0950268812002282
19. Pebody RG, Andrews N, Fleming DM, McMenamin J, Cottrell S, Smyth B, et al. Age-specifc vaccine effectiveness of seasonal 2010/2011 and pandemic infuenza A(H1N1) 2009 vaccines in preventing infuenza in the United Kingdom. Epidemiol Infect 2012: 1-11; In Press. PMID: 22691710
20. Castilla J, Martínez-Artola V, Salcedo E, Martínez-Baz I, Cenoz MG, Guevara M, et al.; Network for Infuenza Surveillance in Hospitals of Navarre. Vaccine effectiveness in preventing infuenza hos-pitalizations in Navarre, Spain, 2010-2011: cohort and case-control study. Vaccine 2012; 30: 195-200; PMID: 22100636; http://dx.doi.org/10.1016/j. v a c c i ne. 2 011.11.0 2 4
21. Emborg HD, Krause TG, Hviid A, Simonsen J, Mølbak K. Effectiveness of vaccine against pandemic infuenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10. BMJ 2012; 344:d7901; PMID: 22277542; http://dx.doi.org/10.1136/bmj.d7901
22. Pelat C, Falchi A, Carrat F, Mosnier A, Bonmarin I, Turbelin C, et al. Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) infuenza: estimations from surveillance data in France. PLoS One 2011; 6:e19621; PMID: 215730 05; http://dx.doi.org/10.1371/journal. p on e.0 019 6 21
23. Petrie JG, Ohmit SE, Johnson E, Cross RT, Monto AS. Effcacy studies of infuenza vaccines: effect of end points used and characteristics of vaccine failures. J Infect Dis 2011; 203: 1309-15; PMID: 21378375; http://dx.doi.org/10. 1093/infdis/jir015
24. Hannoun C, Dab W, Cohen JM. A new infuenza surveillance system in France: the Ile-de-France "GROG". 1. Principles and methodology. Eur J Epidemiol 1989; 5: 285-93; PMID: 2792306; http://dx.doi.org/10.1007/BF00144828 (Pubitemid 19238239)
25. Falchi A, Amoros JP, Arena C, Arrighi J, Casabianca F, Andreoletti L, et al. Genetic structure of human A/H1N1 and A/H3N2 infuenza virus on Corsica Island: phylogenetic analysis and vaccine strain match, 2006-2010. PLoS One 2011; 6:e24471; PMID: 21935413; http://dx.doi.org/10.1371/journal. pone.0024471
26. Farrington CP. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 1993; 22: 742-6; PMID: 8225751; http://dx.doi.org/10. 1093/ije/22.4.742 (Pubitemid 23247580)
27. Cohen AL, Taylor T Jr., Farley MM, Schaffner W, Lesher LJ, Gershman KA, et al. An assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United States. PLoS One 2012; 7:e41785; PMID: 22870248; http://dx.doi.org/10.1371/jour-na l.pone.00 41785
28. Privileggio L, Falchi A, Grisoni ML, Souty C, Turbelin C, Fonteneau L, et al. Rates of immunization against pandemic and seasonal infuenza in persons at high risk of severe infuenza illness: a cross-sectional study among patients of the French Sentinelles general practitioners. BMC Public Health 2013; 13: 246; PMID: 23514534; http://dx.doi.org/10.1186/1471-2458-13-246